.
MergerLinks Header Logo

New Deal


Announced

Within3 to acquire rMark Bio.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

software solutions

Domestic

Private

Single Bidder

Pending

Majority

Software

Acquisition

United States

Friendly

Synopsis

Edit

Within3, a provider of digital collaboration service, agreed to acquire rMark Bio, a developer of a business intelligence software. Financial terms were not disclosed. “At any given time, Within3 customers are generating thousands of global insights from internal and external stakeholders on the Within3 platform. rMark’s intelligent technology pulls stakeholder insights from across the enterprise for reference and influence of new life science development projects. In doing so, it packages and delivers insights to life science teams in an actionable, measurable way – more quickly and efficiently than previously possible. When combined with the Within3 platform, our clients will be able to succinctly understand a 360-degree view of the scientific and market signals in their enterprises," Lance Hill, Within3 CEO.

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US